| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide agents for the treatment of a condition mediated by 5-HT<SB POS="POST">4</SB>receptor activity such as gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, nonulcer dyspepsia, functional dyspepsia, irritable bowel syndrome (IBS), constipation, dyspepsia, esophagitis, gastroesophageal disease, nausea, central nervous system disease, Alzheimer's disease, cognitive disorder, emesis, migraine, neurological disease, pain, cardiovascular disorders such as cardiac failure and heart arrhythmia, diabetes and apnea syndrome. <P>SOLUTION: This invention relates to compounds of formula (I). <P>COPYRIGHT: (C)2012,JPO&INPIT |
